Attention Deficit Hyperactivity Disorder
📧 Sign up to get email alerts when something new happens for Attention Deficit Hyperactivity Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-11-26Clinical Trial Update: Safety and Efficacy of SPD503 in Treating Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-17 [Phase 3]
Phase 3 study evaluating SPD503 for ADHD in children 6-17 has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2009-11-26Clinical Trial Update: Safety and Tolerability of SPD503 and Psychostimulants in Children and Adolescents Aged 6-17 With Attention-Deficit/Hyperactivity Disorder (ADHD) [Phase 2]
Phase 2 clinical trial update on safety and tolerability of SPD503 and psychostimulants in children and adolescents with ADHD; results compl…
-
CLINICAL_TRIALS trial_result · 2009-10-30Clinical Trial Update: An Exploratory Trial of AZD3480 (TC-1734) for the Treatment of Adult Attention-Deficit/Hyperactivity Disorder (ADHD) [Phase 2]
The document reports the completion of a Phase 2 exploratory trial of AZD3480 (TC-1734) for adult attention-deficit/hyperactivity disorder. …
-
CLINICAL_TRIALS trial_result · 2009-10-15Clinical Trial Update: Safety and Efficacy of SPD503 in Treating ADHD in Children and Adolescents Aged 6-17 [Phase 3]
Phase 3 trial update on SPD503 for ADHD in children and adolescents shows results and completion.
-
CLINICAL_TRIALS trial_result · 2009-10-14Clinical Trial Update: Safety, Tolerability and Efficacy of SPD503 in Treating ADHD in Children Aged 6-17 [Phase 2]
Phase 2 clinical trial update on SPD503 for treating ADHD in children 6-17, reporting safety, tolerability, and efficacy.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-10-01Clinical Trial Update: Mazindol in Children With ADHD : Open-label, Efficacy, Safety and Pharmacokinetic Pilot Trial
This open-label pilot trial evaluated mazindol in children with attention-deficit/hyperactivity disorder, assessing efficacy, safety, and ph…
-
CLINICAL_TRIALS trial_result · 2009-09-22Clinical Trial Update: Methylphenidate Treatment Response Study of Genetic Polymorphism in Attention Deficit Hyperactivity Disorder(ADHD) [Phase 4]
A Phase 4 clinical trial update from Seoul National University Hospital is evaluating genetic polymorphisms as predictors of methylphenidate…
-
CLINICAL_TRIALS trial_result · 2009-09-15Clinical Trial Update: Safety Study of Atomoxetine and Cerebrovascular Outcomes
This trial update reports the completed safety study of atomoxetine examining cerebrovascular outcomes in ADHD patients.
-
CLINICAL_TRIALS trial_result · 2009-09-01Clinical Trial Update: Dose-Optimization Study Evaluating the Efficacy, Safety and Tolerability of Vyvanse (Lisdexamfetamine Dimesylate) in Children Aged 6-12 Diagnosed With ADHD [Phase 4]
A Phase 4 dose-optimization study of Vyvanse (lisdexamfetamine dimesylate) in children aged 6-12 with ADHD completed with posted results in …
-
CLINICAL_TRIALS trial_result · 2009-08-17Clinical Trial Update: The Role of Adverse Environment Factors, Family Functioning and Parental Psychopathology in the Response to Treatment With Methylphenidate in Children and Adolescents With Attention Deficit/Hyperactivity Disorder [Phase 4]
Phase 4 clinical trial evaluating how adverse environmental factors, family functioning, and parental psychopathology affect response to met…
-
CLINICAL_TRIALS trial_result · 2009-08-11Clinical Trial Update: A Trial of Computer-based Attention-training Systems in Children With Attention Deficit Hyperactivity Disorder (ADHD) [NA]
A completed clinical trial evaluating computer-based attention-training systems in children with Attention Deficit Hyperactivity Disorder.
-
CLINICAL_TRIALS trial_result · 2009-07-28Clinical Trial Update: Methylphenidate in Children and Adolescents With Pervasive Developmental Disorders [NA]
This trial update reports on the completion of a study evaluating methylphenidate for children and adolescents with pervasive developmental …
-
CLINICAL_TRIALS trial_result · 2009-07-27Clinical Trial Update: The Therapeutic Effects of Barkley's Parenting Management Program for Taiwanese School-Aged Children With Attention Deficit/Hyperactivity Disorder (ADHD) [Phase 1]
This document provides an update on a Phase 1 clinical trial evaluating Barkley's Parenting Management Program for Taiwanese school-aged chi…
-
CLINICAL_TRIALS trial_result · 2009-07-17Clinical Trial Update: An Open-label Study of NRP104 in Adults With Attention Deficit Hyperactivity Disorder (ADHD) [Phase 3]
This is an open-label Phase 3 trial update of NRP104 in adults with attention-deficit/hyperactivity disorder; the study is completed and res…
-
CLINICAL_TRIALS trial_result · 2009-07-08Clinical Trial Update: Atomoxetine Versus Placebo for Symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents With Autism Spectrum Disorder [Phase 4]
A Phase 4 trial comparing atomoxetine to placebo for ADHD symptoms in children and adolescents with autism spectrum disorder; results were p…
-
CLINICAL_TRIALS trial_result · 2009-07-02Clinical Trial Update: Study to Assess the Safety and Efficacy of NRP104 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD) [Phase 3]
The Phase 3 trial evaluating NRP104 in adults with Attention-Deficit/Hyperactivity Disorder has completed. The snippet does not report the t…
-
CLINICAL_TRIALS trial_result · 2009-06-11Clinical Trial Update: Evaluate the Efficacy &Safety of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD [Phase 3]
Phase 3 trial completed evaluating the efficacy and safety of the methylphenidate transdermal system (MTS) in adolescents aged 13-17 with AD…
-
CLINICAL_TRIALS trial_result · 2009-06-10Clinical Trial Update: Atomoxetine Phase 2 Study in Japanese Adult Patients With Attention Deficit/Hyperactivity Disorder (ADHD) [Phase 2]
This update reports the results of a Phase 2 trial of atomoxetine in Japanese adults with attention deficit hyperactivity disorder, with the…
-
CLINICAL_TRIALS trial_result · 2009-06-05Clinical Trial Update: A Classroom Study to Assess the Time of Onset of Vyvanse (Lisdexamfetamine Dimesylate) in Pediatric Subjects Aged 6-12 With Attention Deficit/Hyperactivity Disorder (ADHD) [Phase 3]
Phase 3 clinical trial assessing time of onset of Vyvanse (lisdexamfetamine dimesylate) in children aged 6-12 with ADHD; study completed wit…
-
CLINICAL_TRIALS trial_result · 2009-05-21Clinical Trial Update: Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) in Children [Phase 3]
A Phase 3 clinical trial evaluating clonidine for attention-deficit/hyperactivity disorder in children has completed; sponsor is the Univers…
-
CLINICAL_TRIALS trial_result · 2009-05-21Clinical Trial Update: Preschool Supplement to Clonidine in ADHD (Kiddie-CAT) [Phase 2]
Phase 2 clinical trial update of Kiddie-CAT, a preschool supplement to clonidine for Attention Deficit Hyperactivity Disorder; the study has…
-
CLINICAL_TRIALS trial_result · 2009-04-07Clinical Trial Update: Efficacy, Safety, and Tolerability of Ambien (Zolpidem) in the Treatment of Children Ages 6 to 17 With Attention Deficit Hyperactivity Disorder (ADHD)-Associated Insomnia [Phase 3]
A Phase 3 trial evaluated zolpidem (Ambien) for ADHD-associated insomnia in children aged 6 to 17, assessing efficacy, safety, and tolerabil…
-
CLINICAL_TRIALS trial_result · 2009-03-30Clinical Trial Update: A Study of Dex-methylphenidate Extended Release in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD) [Phase 4]
Phase 4 trial evaluating dexmethylphenidate extended-release for attention-deficit/hyperactivity disorder in children aged 6 to 12 has compl…
-
CLINICAL_TRIALS trial_result · 2009-03-06Clinical Trial Update: Characterization of Dermal Reactions in Pediatric Patients With ADHD Using DAYTRANA [Phase 4]
Phase 4 trial update characterizes dermal reactions in children with ADHD treated with the Daytrana methylphenidate patch. Results were post…
-
CLINICAL_TRIALS trial_result · 2009-02-12Clinical Trial Update: Genetic Polymorphism and OROS-Methylphenidate Treatment in Attention Deficit Hyperactivity Disorder(ADHD) [Phase 4]
Phase 4 study evaluating the influence of genetic polymorphisms on response to osmotic-release methylphenidate in attention-deficit/hyperact…